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Alzheimer’s disease (AD) is the most common neurodegenerative disease, characterized by 
amyloid-beta plaques, neurofibrillary tangles and neuroinflammation. Autophagy has been 
associated with several neurodegenerative diseases. Recently, autophagy has been linked to 
the regulation of the inflammatory response in macrophages. My thesis investigates how an 
impairment of autophagy influences the inflammatory response of microglia. We used 
Beclin1 heterozygous (Becn1+/-) mice as a model of impaired autophagy. Beclin1 plays a role 
in the initiation of autophagy and was shown to be decreased in microglia isolated from AD 
patients compared to healthy controls. In vitro, acutely stimulated microglia from neonatal 
Becn1+/- mice exhibited increased expression of the proinflammatory cytokines IL-1beta and 
IL-18 compared to wild type microglia. Both IL-1beta and IL-18 are processed by the NLRP3 
inflammasome pathway. The investigation of this pathway showed an elevated number of 
cells with inflammasomes and increased levels of the inflammasome components NLRP3 and 
cleaved Caspase1 in Becn1+/- microglia. Super resolution microscopy revealed a very close 
association of NLRP3 aggregates and LC3-positive autophagosomes. Interestingly, despite 
suggestions that the murine CALCOCO2 does not function as an autophagic adaptor, we 
discovered CALCOCO2 colocalised with NLRP3 and that its downregulation by siRNA 
knockdown increased IL-1beta release. These data support the notion that selective 
autophagy can impact microglia activation by modulating IL-1beta and IL-18 production via 
NLRP3 degradation. These in vitro data present a mechanism how impaired autophagy could 
contribute to neuroinflammation in AD. 
In vivo analysis of Becn1+/-.APPPS1 mice also demonstrated enhanced IL-1beta levels, but no 
differences in amyloid beta pathology, nor phagocytic capacity. The constitutive 
heterozygosity of Beclin1 might be responsible for the milder effects in vivo. Therefore, we 
performed studies utilizing more sophisticated models targeting immune cells specifically. 
The first model, Aldh1l1-iCre.Becn1-flox, targets Becn1 deletion specifically in astrocytes in 
the central nervous system after injection with the drug tamoxifen. Peripherally, Aldh1l1 is 
also expressed by hepatocytes. The Aldh1l1-iCre.Becn1-flox mice suffered from peripheral 
damage in the liver 10 days after tamoxifen injection, and can therefore not be used in 
further studies. The second model, Cx3Cr1-iCre.Becn1-flox, targets Becn1 deletion 
specifically in microglia in the central nervous system, and will be crossed to the APPPS1 
mice to create a tool to study the role of Beclin1 in microglia in neuroinflammation and 
neurodegeneration. This new tool and the data generated in this work will support a new 
direction of research, to unravel the therapeutic potential of autophagy-dependent 
inflammation in neurodegenerative diseases. 
  






Die Alzheimer-Krankheit (AD) ist die häufigste neurodegenerative Erkrankung, die durch 
Amyloid-Beta-Plaques, neurofibrilläre Verwicklungen und Neuroinflammation 
gekennzeichnet ist. Autophagie wurde mit mehreren neurodegenerativen Erkrankungen in 
Verbindung gebracht. Vor Kurzem wurde Autophagie mit der Regulierung der 
Entzündungsreaktion in Makrophagen in Verbindung gebracht. Meine Dissertation 
untersucht, wie eine Beeinträchtigung der Autophagie die Entzündungsreaktion von 
Mikroglia beeinflusst. Wir haben Beclin1-heterozygote (Becn1+/-) Mäuse als Modell für 
eingeschränkte Autophagie verwendet. Beclin1 spielt eine Rolle bei der Initiierung der 
Autophagie und es wurde gezeigt, dass es bei aus AD-Patienten isolierten Mikrogliazellen im 
Vergleich zu gesunden Kontrollen abnimmt. Akut stimulierte Mikroglia aus neonatalen 
Becn1+/– Mäusen zeigten in vitro eine erhöhte Expression der proinflammatorischen Zytokine 
IL-1beta und IL-18 im Vergleich zu Wildtyp-Mikroglia. Sowohl IL-1beta als auch IL-18 werden 
vom NLRP3-Inflammasom-Weg verarbeitet. Die Untersuchung dieses Weges zeigte eine 
erhöhte Anzahl von Zellen mit Inflammasomen und erhöhte Spiegel der 
Inflammasomenkomponenten NLRP3 und gespaltenen Caspase1 in Becn1+/– Mikroglia. 
Super-Resolution-Mikroskopie zeigte eine sehr enge Lokalisation von NLRP3-Aggregaten und 
LC3-positiven Autophagosomen. Interessanterweise haben wir trotz der Kritik, dass das 
murine CALCOCO2 nicht als autophagischer Adapter fungiert, entdeckt, dass CALCOCO2 mit 
NLRP3 kolokalisiert und dass die Herunterregulierung durch siRNA die IL-1beta-Freisetzung 
erhöhte. Diese Daten stützen die Ansicht, dass selektive Autophagie die Mikroglia-
Aktivierung beeinflussen kann, indem die IL-1beta- und IL-18-Produktion durch NLRP3-
Abbau moduliert wird. Diese in vitro Daten stellen einen Mechanismus dar, wie eine gestörte 
Autophagie zur Neuroinflammation bei AD beitragen kann. 
In vivo Analysen von Becn1+/–.APPPS1 Mäusen zeigten ebenfalls erhöhte IL-1beta-Spiegel, 
jedoch keine Unterschiede in der Amyloid-Beta-Pathologie und auch keine in Bezug auf die 
Phagozytosekapazität. Die konstitutive Heterozygotie von Beclin1 könnte für die geringen 
Auswirkungen in vivo verantwortlich sein. Daher etablierten zwei neue Modelle, die speziell 
auf Immunzellen abzielten. Das erste Modell, Aldh1l1-iCre.Becn1-Flox, zielt auf die Becn1-
Deletion spezifisch in Astrozyten im zentralen Nervensystem nach Injektion des 
Arzneimittels Tamoxifen ab. In der Peripherie wird Aldh1l1 auch von Hepatozyten 
exprimiert. Die Aldh1l1-iCre.Becn1-Flox Mäuse erlitten 10 Tage nach Tamoxifen-Injektion 
eine periphere Schädigung der Leber und können daher nicht in weiteren Studien verwendet 
werden. Das zweite Modell, Cx3Cr1-iCre.Becn1-flox, zielt auf die Becn1-Deletion speziell in 
Mikroglia im Zentralnervensystem ab und wird mit den APPPS1-Mäusen gekreuzt, um ein 
Modell für die Untersuchung der Rolle von Beclin1 in Mikroglia bei Neuroinflammation und 
Neurodegeneration darzustellen. Dieses neue Mausmodell und die in dieser Arbeit 
generierten Daten werden eine neue Richtung der Forschung unterstützen, um das 
therapeutische Potenzial autophagieabhängiger Entzündungen bei neurodegenerativen 
Erkrankungen zu ermitteln.  








Alzheimer’s disease (AD) is the most common neurodegenerative disease, with increasing 
prevalence in our aging society (Querfurth & LaFerla, 2010). The disease was first described 
by Alois Alzheimer in the beginning of the 1900s who found extracellular protein aggregates 
and intraneuronal fibers in patient tissue. The co-existence of extracellular amyloid-beta 
(Abeta) plaques and intracellular phosphorylated tau tangles are still considered as the 
hallmarks of AD pathology and are routinely used for diagnosis (Montine, Phelps et al, 2012). 
Despite uncovering parts of the disease-related mechanisms, a treatment or a cure for this 
devastating disease is still far from being found.  
 
One of the more recent discoveries in the field of AD research is the influence of glial cells 
and neuroinflammation upon pathophysiology. The importance of non-neuronal cells in 
maintaining brain homeostasis and responding to danger signals has long been neglected 
but is now becoming increasingly relevant. The exact role of neuroinflammation in the 
pathology of AD remains debated. It was assumed that the plaques and tangles activate the 
brain’s intrinsic immune cells, namely microglia and astrocytes, inducing the release of pro-
inflammatory cytokines and chemokines. In line with this hypothesis, microgliosis and 
astrogliosis as well as complement-activated oligodendrocytes can all be found in the cortex 
and hippocampus, the brain regions affected by AD pathology. However, wild type mice 
challenged prenatally with the viral mimic PolyI:C develop an AD-like phenotype (Krstic, 
Madhusudan et al, 2012), leading to a new hypothesis that neuroinflammation might occur 
much earlier in the disease, and can be considered a driver of pathology rather than a 
consequence (Heppner, Ransohoff et al, 2015). This hypothesis opened up a new possible 
treatment approach through targeting the AD pathophysiology via immunomodulation.   
 
Immunomodulation is based on the idea that microglia, the innate immune cells of the brain, 
are able to phagocytose Abeta, therefore counteracting the aggregation of Abeta into 
pathological plaques. Upon uptake of Abeta, the mechanisms of its degradation are still 
unclear. One potential pathway of removing intracellular Abeta is via macro-autophagy 
(referred to as autophagy).      
 
Autophagy 
Autophagy has been associated with several neurodegenerative diseases and aging. This 
well-preserved pathway is present in organisms ranging from yeast to human, and found in 
every cell of the human body. The main purposes of autophagy are to maintain cell 
homeostasis and to prevent cell death by degrading large proteins or protein aggregates that 
cannot be targeted by the proteasome due to their size. Such large proteins are removed in 
an organized manner via the formation of autophagosomes (Fig. 1). Here, protein complexes 




of several autophagy-related proteins (ATGs) create a double membrane. Autophagic 
adaptor proteins connect to the cargo and transfer the cargo to the double membrane of the 
phagophore. Once the cargo attaches to the membrane it closes and the autophagosome 
fuses with a lysosome to allow for degradation of the cargo into amino acids by proteases in 
an acidic environment. Finally, the autolysosome is broken down which releases the amino 
acids to be re-used as building blocks for new proteins (see Fig. 1, reviewed in more detail in 
(Menzies, Fleming et al, 2015)).  
 
 
Figure 1. Schematic representation of the autophagy pathway 
Protein complexes, like the BECN1 complex, initiate vesicle nucleation by forming a double membrane, 
called the phagophore. LC3-I is phosphorylated upon the formation of the phagophore, and recruited 
to the membrane as LC3-II. A cytoplasmic cargo is bound by autophagic adaptor proteins and shuttled 
towards the phagophore. Once the adaptor protein carrying the cargo binds to LC3-II on the 
phagophore, the membrane closes and forms an autophagosome. The autophagosome fuses with a 
lysosome to an autolysosome. The content of the autolysosome is degraded by the proteases in acidic 
pH. The degraded content is released back into the cytoplasm to be re-used by the cell. (designed with 
Biorender, based on (Yang, Kaushal et al, 2008)) 
 
During the aging process autophagy becomes impaired, leading to the hypothesis that 
decreased autophagy is one of the causes of age-induced neurodegenerative diseases 
(Menzies, Fleming et al, 2015). In support of this hypothesis, Pickford et al. could show that 
autophagy levels negatively correlate with neurodegenerative disease by comparing Beclin1 
(BECN1/ATG6) levels in cortex samples of AD patients, patients with mild cognitive 
impairment and healthy age-matched controls (Pickford, Masliah et al, 2008). BECN1 is a 
multifunctional protein with roles in: autophagy, inducing vesicle nucleation (Suzuki, Kubota 
et al, 2007); phagocytosis, by recycling transmembrane receptors (Lucin, O’Brien et al, 2013); 
neuroprotection, by controlling TGF-beta signaling (O’Brien, Bonanno et al, 2015); and 
development, illustrated by the embryonic lethality of Becn1-/- mice (Yue, Jin et al, 2003). 
The Becn1+/- mouse is used as an alternative model and does not show an abnormal 
phenotype, apart from a higher incidence of tumors at a later age (Qu, Yu et al, 2003). 




Pickford et al. crossed the Becn1+/- mice to AD-like T41 mice, and showed that a decreased 
level of autophagy in these mice led to a worsening of Abeta pathology (Pickford, Masliah et 
al, 2008).  
 
Maintaining cell homeostasis is especially important for long-lived cells, such as neurons, and 
the decrease in BECN1 in the human cortex samples was therefore mainly attributed to 
neuronal autophagy levels. However, a significant decrease in BECN1 protein levels was 
found in microglia isolated from AD patients several years later (Lucin, O’Brien et al, 2013). 
This postulated a correlation between the immune system and autophagy, which could have 
downstream effects upon neurodegenerative processes. 
 
Autophagy in innate immunity 
Several studies have investigated the role of autophagy in inflammation, depleting different 
tissue macrophages of the autophagic proteins ATG5 (Lodder, Denaës et al, 2015), ATG7 
(Lee, Kim et al, 2016) or ATG16L1 (Saitoh, Fujita et al, 2008). The lack of these proteins 
worsened inflammatory diseases in different models (Lee, Kim et al, 2016; Lodder, Denaës et 
al, 2015; Saitoh, Fujita et al, 2008), or induced pro-inflammatory cytokine release in vitro (Ye, 
Jiang et al, 2017). This data supports the hypothesis that decreased autophagy in peripheral 
macrophages correlates with an exacerbation of immunological diseases.   
Within the central nervous system, microglia are the first line of defense, and were therefore 
previously addressed as brain macrophages. However, recently it was discovered that 
microglia derive from the yolk sac at E9.5, rather than from hematopoietic cells like other 
tissue macrophages (Ginhoux, Greter et al, 2010). This difference in ontogeny is also shown 
in their genetic signature, making microglia a special group of phagocytic immune cells 
(Hickman, Kingery et al, 2013). Recent discoveries support that the combination of ontogeny 
and the CNS environment accounts for a unique microglial identity (Bennett, Bennett et al, 
2018). Thus, we should be careful transferring our knowledge of macrophages directly to 
microglia. Regarding autophagy, only few studies focused specifically on microglia, with 
conflicting results. François et al. studied LPS treated microglia and showed no relation 
between cytokine release and blockage of autophagy (François, Terro et al, 2013). In another 
study, Cho et al. investigated the role of Abeta and autophagy in microglia, showing that 
fibrillary Abeta is degraded by autophagy, and that fibrillary Abeta-induced NLRP3 




Since the literature describes a role for autophagy in inflammation and linking decreased 
BECN1 protein levels to neurodegeneration, we hypothesized that microglial BECN1 plays a 








RESULTS AND DISCUSSION 
Becn1 heterozygosity in vitro 
As a first step, we analyzed the BECN1 levels in Becn1+/- and wild type neonatal microglia, 
which showed a ~40% reduction of BECN1 in Becn1+/- microglia (Houtman, Freitag et al, 
2019). Next, the inflammatory response of Becn1+/- and wild type neonatal microglia was 
analyzed in vitro. Wild type as well as Becn1+/- microglia were treated with the commonly 
used inflammatory stimuli combination of LPS and ATP.  The binding of LPS to TLR4 led to 
the release of pro-inflammatory cytokines like TNF-alpha and IL-6 (interleukin 6), and 
subsequent exposure to ATP released IL-1beta and IL-18 (Houtman, Freitag et al, 2019). 
Interestingly, the Becn1+/- microglia, showing a decreased amount of autophagy, released 
more IL-1beta and IL-18 than wild type microglia. Both of these cytokines are cleaved to gain 
their activated form by the NLRP3 inflammasome (Fig. 2).  
 
 
Figure 2. Schematic representation of the inflammasome pathway (Walsh, Muruve et al, 2014)  
Binding of the TLR4 receptor by signal 1, for instance LPS, primes the inflammasome pathway. Pro-IL-
1beta and pro-IL-18 are transcribed and translated, as well as NLRP3. A second signal, for instance 
ATP, causes the NLRP3 molecules to oligomerize and recruit ASC and Caspase 1. This protein complex 
called the inflammasome releases the activated form of Caspase 1, cleaves pro-IL-1beta and pro-IL-18, 
upon which the active forms of the cytokines are released.  
 
As presented in our publication (Houtman, Freitag et al, 2019), we discovered that several 
components of the NLRP3 inflammasome – NLRP3 protein level, ASC specks and activated 
caspase 1 – are increased in Becn1+/- microglia. Immunocytochemistry of Becn1+/- microglia 
showed colocalization of NLRP3 with LC3, a protein found on the autophagosomal 




membrane. Super resolution microscopy (Structured Illumination Microscopy, SIM) and 
subsequent radial plot analysis confirmed that NLRP3 and LC3-II were located on the same 
organelle, supporting the link of autophagy to inflammation (Houtman, Freitag et al, 2019). 
 
After defining the relevance of BECN1 in autophagy in the response to inflammatory stimuli, 




As BECN1 is known to play a role in retromer recycling of transmembrane receptors involved 
in phagocytosis (Lucin, O’Brien et al, 2013), we investigated the phagocytic capacity of 
Becn1+/- microglia. As described in Houtman et al., we performed an ex vivo slice assay based 
on an earlier publication from our lab (Krabbe, Halle et al, 2013). Comparing Becn1+/- and 
wild type animals of 4 months old, we did not observe any difference in phagocytic capacity 
(Houtman, Freitag et al, 2019). 
In order to check the phagocytic capacity of neonatal microglia, we established the pHrodo 
E. coli bioparticles assay (see methods section below). When comparing neonatal wild type 
microglia with neonatal Becn1+/- microglia we did not observe any difference in phagocytic 
capacity (Fig 3A).  
 
 
Figure 3. Phagocytosis assays with neonatal microglia  
A) The pHrodo bead assay is able to measure phagocytosis of neonatal wild type and Becn1+/- 
microglia. Cytochalasin D is a pharmaceutical impairing actin filament polymerisation, which also 
blocks phagocytosis, and is used as a negative control. Phagocytic capacity was normalized to wild 
type non-treated samples. There is no difference in phagocytic capacity between wild type and 
Becn1+/- microglia. N = 3. B) The pH rodo bead assay performed on siRNA treated neonatal microglia. 
The siRNA treatment itself (scrambled siRNA control) blocked phagocytic capacity in a similar manner 
as cytochalasin D. N=3. 
 
Since BECN1 protein levels in Becn1 +/- microglia are only reduced by 50%, the remaining 
protein could still influence phagocytosis. We therefore performed an siRNA knockdown of 
Becn1 in the Becn1+/- microglia to achieve a stronger reduction of BECN1 protein expression. 
Unfortunately, the siRNA treatment itself affected phagocytic capacity, since the scrambled 
siRNA treated cells presented with decreased phagocytic capacity as well (Fig 3B). Thus, in 




our hands the partially depleted BECN1 levels did not influence phagocytic capacity, which is 
contrary to previously published results (Lucin, O’Brien et al, 2013). This discrepancy could 
be due to different experimental approaches. Lucin et al., utilized BV2 cells with a strong 
BECN1 knockdown, an immortalized microglia cell line that is genetically very different from 
microglia (Das, Kim et al, 2016), for their phagocytosis experiments. Additionally, Lucin et al. 
employed different assays to assess phagocytic capacity.  
 
Based on the increase of the inflammasome components in the Becn1+/- microglia, the 
colocalization of NLRP3 and LC3 as well as the lack of change in phagocytic capacity in the 
Becn1+/- cells, we specified our hypothesis from ‘microglial BECN1 plays a role in 
neuroinflammation’ to ‘microglial autophagy regulates neuroinflammation by degrading 
NLRP3’.  
 
CALCOCO2 as possible autophagic adaptor 
In support of this hypothesis, we discovered a relation between CALCOCO2/NDP52 and 
NLRP3 as well as between CALCOCO2 and IL-1beta release (Houtman, Freitag et al, 2019). 
CALCOCO2 is described as one of the autophagic adaptor proteins, responsible for shuttling 
cargo to the autophagosomal membrane.  
 
Within the community, there are some doubts that CALCOCO2 exists and is functional in 
mice. In order to proof that it exists and functions, we performed an extensive literature 
study and found NCBI records of the validated mRNA (NM_001271018.1) and amino acid 
(NP_001257947.1) sequences of murine Calcoco2 in the NCBI gene and protein bank. On top 
of that, a comparison between the protein sequence of human (isoform1) and murine 
NDP52 show 128 identical amino acids in the N-terminal region. This indicates that the 
murine NDP52 protein sequence as presented by Tumbarello et al. (Tumbarello, Manna et 
al, 2015) is related to the human one. Finally, using cDNA of murine microglia, the 
amplification of the coding sequence of murine CALCOCO2 resulted in a band of around 
1000 bp. In western blots (with an antibody raised against the N-terminal domain of human 
NDP52/CALCOCO2) a band of about 34 kDa was detected (Fig. 5E of (Houtman, Freitag et al, 
2019)), which is in agreement with the published coding sequence. Kim et al. also showed 
that murine NDP52 mRNA and protein has been detected in the brain of AD model mice 
(Kim, Lee et al, 2014). 
 
Although we established the presence of CALCOCO2 in mice, we are also aware that the 
murine CALCOCO2 is truncated. On the other hand, the NCBI protein bank showed four 
additional alternatively spliced transcript variants of NDP52 that are all shorter, indicating 
possible functions of truncated NDP52 also in human cells.  
 
The proteins can be dissected into domains, hNDP52 consists of a C-terminal LIM-like 
domain (zinc fingers), a Galectin-8 domain, an intermediate coiled coil domain, a non-
canonical LC3-interacting region motif for LC3C interaction (LIR), and an N-terminal SKICH 




domain. The truncated mNDP52 still contains the intermediate coiled coil domain, a non-
canonical LC3-interacting region motif for LC3C interaction (LIR), and a N-terminal SKICH 
domain (see Fig. 4 as well as (Tumbarello, Manna et al, 2015)).  
 
The domains that remain in murine CALCOCO2 have been shown to bind a number of 
proteins, and have been related to autophagy. The non-canonical LIR motif selectively binds 
LC3C, which recruits all ATG8 orthologues to the autophagosome (von Muhlinen, Akutsu et 
al, 2012). The SKICH domain of hNDP52 has been shown to bind phosphorylated tau and 
amyloid-beta (Jo, Gundemir et al, 2014), damaged mitochondria (Furuya, Kakuta et al, 2018), 
TRIF and TRAF6 (Inomata & Into, 2012). In the protein TAX1BP1/CALCOCO3 the SKICH 
domain is thought to be required for the autophagy function (Yang, Wang et al, 2015). The 
LIM-like domain that is missing in murine CALCOCO2 is responsible for ubiquitin binding, but 
autophagic degradation of for instance tau and amyloid-beta is suggested to be ubiquitin 




Figure 4. Evolutionary analysis of CALCOCO1, CALCOCO2/NDP52 and TAX1BP1/CALCOCO3  
The analysis shows that murine CALCOCO2 has a truncated version of CALCOCO2, lacking the zinc 
finger domain. It also shows murine CALCOCO2 is related to the human variant. (Figure from 
(Tumbarello, Manna et al, 2015)) 
 
As presented in Houtman et al., immunocytochemistry showed a colocalization of NLRP3 and 
CALCOCO2 and further analysis by SIM confirmed this. A radial plot analysis of the SIM 
pictures showed that CALCOCO2 is significantly closer to NLRP3 than LC3, although NLRP3 
and LC3 are still part of the same organelle. We used siRNA knockdown of CALCOCO2 in wild 
type neonatal microglia to confirm its relevance in the inflammasome pathway and indeed 
observed an increased release of IL-1beta (Houtman, Freitag et al, 2019). 
 
We also performed an immunoprecipitation of NLRP3 with CALCOCO2, however, we did not 
obtain a convincing band. As autophagy is an ongoing process, the connection between 
NLRP3 and CALCOCO2 is only temporary. The lack of a band appears therefore to be rather a 




technical limitation. The small percentage of cells displaying a colocalization of NLRP3 and 
CALCOCO2 in immunocytochemistry supports this hypothesis.  
 
Based on the literature and the above mentioned data we conclude that, although the 
mouse NDP52 is truncated and therefore missing the ubiquitin-binding zinc finger domains, 
this does not mean it is dysfunctional per se. mNDP52 could still play a role in autophagy, 
most likely in a slightly different way as the traditional autophagy adaptors, since mNDP52 
cannot bind ubiquitin. mNDP52 might require a second protein or a protein complex to 
connect the cargo to the phagophore. Future studies will have to unravel the exact 
mechanism. However, the domains that are present in mNDP52 have been shown to be 
relevant in autophagic degradation of different cargo types.  
 
We propose that the role of mNDP52/CALCOCO2 in decreasing IL-1beta release is mediated 
via autophagy. We hypothesize autophagic degradation of the inflammasome by binding of 
NLRP3 to the SKICH domain and subsequent binding of LC3-II on the phagophore by the LIR 
domain present in mNDP52 or in complex with one or more additional proteins.  
 
Taken together, our data show that the activity of the NLRP3 inflammasome is controlled by 
autophagy in microglia in vitro, and suggest CALCOCO2 might shuttle NLRP3 to the 
autophagosome. When autophagy is decreased like in Becn1+/- microglia, or levels of 
CALCOCO2 are decreased by siRNA knockdown, it leads to increased IL-1beta release.  
 
Becn1 heterozygosity in vivo 
The fascinating in vitro data prompted us to investigate Becn1 heterozygosity in vivo. Until 
now, there was only one study analyzing Becn1 heterozygosity and AD in vivo. Pickford et al. 
crossed Becn1+/- mice to the T41 AD-like mouse model, which reduced neuronal autophagy, 
disrupted lysosomes, promoted intracellular and extracellular Abeta accumulation, and 
resulted in neurodegeneration (Pickford, Masliah et al, 2008). We therefore investigated the 
link between autophagy-controlled inflammation and Abeta pathology by crossing Becn1+/- 
mice to another AD-like mouse model, APPPS1 (Radde, Bolmont et al, 2006). APPPS1 mice 
are characterized by a fast disease progression, showing their first plaques already at 2 
months compared to 3-4 months in the T41 mice (Rockenstein, Mallory et al, 2001). We 
analyzed whole brain lysates of double transgenic APPPS1.Becn1+/- mice, single transgenic 
APPPS1 and Becn1+/- mice, and wild type mice over time. When assessing pro-inflammatory 
cytokines, there was a significant increase in IL-1beta release in APPPS1.Becn1+/- mice 
compared to wild type mice at the age of 4- and 8-months. The brain lysates of APPPS1 mice 
appeared to contain more IL-1beta, although this was not significant (Houtman, Freitag et al, 
2019). Thus, the inflammasome pathway seems to be activated in response to Abeta 
pathology, yet a decrease in autophagy leads to significantly increased cytokine release.   
Despite these changes in the inflammatory milieu, Abeta load was unchanged between the 
APPPS1 and APPPS1.Becn1+/- mice (Houtman, Freitag et al, 2019). Considering that we did 
not find a decrease in phagocytic capacity of Becn1+/- microglia, Abeta clearance is probably 




also not affected in the APPPS1 context, explaining why no effect upon amyloid beta 
pathology was seen. As mentioned before, APPPS1 mice have a more aggressive pathology 
than T41 mice, as well as a presenilin mutation, which could explain why Pickford et al. did 
find a difference in Abeta pathology.  
Since the model used is a constitutive Becn1+/- mouse, all cell types express only one Becn1 
allele. This might also play an additional role in the increased IL-1beta levels in this in vivo 
model. IL-1beta binds to the IL1 receptor that is ubiquitously expressed and activates many 
different pathways (Weber, Wasiliew et al, 2010). It is possible that the decreased BECN1 
levels in the other CNS cells influence the uptake and degradation of IL-1beta, leading to 
increased IL-1beta levels. 
 
Since the in vitro data did show a clear role for BECN1 and autophagy in controlling 
microglial inflammasome activity and IL-1beta and IL-18 release, we set out to create a more 
sophisticated model to link AD-pathology to autophagy and inflammation specifically via 
microglia.  
 
Microglia-specific knockdown of Becn1 
In order to generate a microglia specific and complete knockdown of Becn1, we decided to 
use an inducible Cre-flox system in APPPS1 mice. First, Cx3Cr1CreERT mice were crossbred to 
Becn1flox/flox mice. By putting the expression of the Cre recombinase under the control of the 
Cx3Cr1 promotor, gene excision is carried out specifically in microglia, intestinal 
macrophages and kidney macrophages, but not other myeloid cells (Yona, Kim et al, 2013). 
However, due to the higher proliferation rate of peripheral monocytes and macrophages, 
the gene deletion is microglia specific after approximately 7 weeks (Yona, Kim et al, 2013). In 
this model, Cre recombinase activation is also linked to estrogen receptor thymidine 
induction, which can be achieved by treatment with its agonist tamoxifen. In Becn1flox/flox 
mice, exons 4-7 of the Becn1 gene are flanked by loxP sites, which are targeted by Cre 
recombinase and deleted via homologous recombination. When treating the 
Cx3Cr1CreERT.Becn1flox/flox mice with tamoxifen, we can therefore induce deletion of Becn1 
specifically in microglia at any chosen time point.  
 
To test the functionality of the Becn1flox/flox mice, we crossed them to CMVCre mice, 
constitutively expressing the Cre recombinase and therefore leading to an immediate 
knockout of exons 4-7 of Becn1 throughout all cell types. Since a full Becn1 knockout is 
embryonic lethal, we compared CMVCre.Becn1wt/flox  to CMVwt.Becn1wt/flox for the flox-excised 
gene by genotyping. Indeed, in CMVCreBecn1wt/flox mice a wild type and floxed-gene were 
detected via PCR whilst in CMVwt.Becn1wt/flox only a wild type gene was amplified, confirming 
the functionality of the Becn1flox/flox mice (Fig. 5A). 
 
To test the microglial-specific Becn1 deletion in the Cx3Cr1CreERT.Becn1flox/flox mice, we 
injected 60-day-old animals intraperitoneal with 75mg/kg tamoxifen diluted in olive oil, and 
a control group with just olive oil, for 5 consecutive days. Twenty days later, we sacrificed 




the mice and isolated peritoneal macrophages, splenocytes, intestinal macrophages and 
microglia (see methods).  
We could not confirm a tamoxifen-dependent deletion of microglial Becn1 by genotyping 
(Fig. 5B). Further analysis of the mice revealed that the Cx3Cr1CreERT mice still possessed the 
neomycin cassette. This cassette is used in the generation of transgenic mouse lines, and 
ought to be removed before use since it was shown to inhibit the expression level of the Cre 
recombinase (Kaartinen & Nagy, 2001). We therefore had to cross the Cx3Cr1CreERT mice to 
the CMVCre mice to knockout the neomycin cassette, and then use the resulting strain to 
generate a functional Cx3Cr1CreERT.Becn1flox/flox line.  
 
To further test our hypothesis that ‘microglial Beclin1 influences neuroinflammation via 
autophagy’ in vivo, future research that is not part of this thesis, will start with characterizing 
the Cx3cr1CreERT.Becn1flox/flox mice. Next, the triple transgenic APPPS1.Cx3cr1CreERT.Becn1flox/flox 




Figure 5. in vivo Cre-flox experiments  
A) Genotyping of CMVCre.Becn1flox/wt mice. Mice #2, #5 and #6 are Cre positive. The genotyping for the 
lox site results in two bands for Cre negative mice, and only the lower wild type band for Cre positive 
mice, confirming the functionality of Cre dependent excision of the lox site. B) Genotyping of 
Cx3Cr1CreERT.Becn1flox/flox mice treated either with tamoxifen or oil as a control. All mice show the band 
for the lox site, the tamoxifen did not induce Cre dependent excision. C) qPCR of tamoxifen treated 
Aldh1l1CreERT.Becn1flox/flox mice. Decreased fold change for the lox flanked exons in the Aldh1l1 and Cre 
expressing cells. No Cre n=2, Cre n=1. D) Western blot of tamoxifen treated Aldh1l1CreERT.Becn1flox/flox 
mice. Decreased BECN1 protein levels for liver cells. No Cre n=2, Cre n=1.  
 




Astrocyte-specific knockdown of Becn1 
In order to assess the role of BECN1 in yet another CNS glial cell type in neuroinflammation 
in vivo we investigated astrocytes. Astrocytes are known to be a modulator of 
neuroinflammatory processes and we hypothesized that decreasing autophagy specifically in 
these cells will increase neuroinflammation as well. We therefore tested this hypothesis by 
crossing the Aldh1l1CreERT model (Winchenbach, Düking et al, 2016), specifically expressing 
Cre recombinase in astrocytes in the CNS, to the Becn1flox/flox mice.  
Surprisingly, ten days after the tamoxifen injections the two mice treated with tamoxifen 
started to sicken and had to be sacrificed. When dissecting these mice, we noticed an 
enlarged and discolored liver, while other organs appeared normal. Lack of autophagy 
proteins in the liver is known to cause hepatomegaly (Komatsu, Waguri et al, 2005; Yoshii, 
Kuma et al, 2016), and Aldh1l1 is expressed by ~80% of liver cells (Winchenbach, Düking et 
al, 2016). Although the hepatomegaly in Atg5 flox/flox and Atg7flox/flox mice was not lethal, the 
Becn1 deletion is still likely to be the cause of the observed serious symptoms of the 
Aldh1l1CreERT.Becn1flox/flox mice. As mentioned before, BECN1 plays a role in more pathways 
than autophagy, and its importance in survival is demonstrated by the different lifespan of 
the complete knockout mice: while Atg5 and Atg7 knockout mice die in the neonatal stage 
(Komatsu, Waguri et al, 2005; Yoshii, Kuma et al, 2016), Becn1 knockout mice do not survive 
beyond E7.5 (Yue, Jin et al, 2003).  
 
To investigate whether tamoxifen could still induce an astrocyte-specific Becn1 knockout in 
these ten days, we isolated astrocytes (see methods) for protein and gene expression 
analyses. Additionally, we prepared cell lysates from the liver and spleen as controls. qPCR 
analysis showed a strong reduction in the expression of Becn1 exon 4-5 in the liver, as well as 
a reduced expression in the astrocytes, albeit not as strong as in the liver. The spleen 
samples served as a negative control, as there is no Aldh1l1 expression in spleen, 
consequently Becn1 exon 4-5 expression was unchanged in spleen (Fig. 5C).  
Next, we assessed BECN1 protein levels by means of western blot, this showed a similar 
pattern. A large reduction in BECN1 protein levels were found in the liver samples whilst a 
smaller reduction could be seen in astrocytes (Fig. 5D), in correspondence to the mRNA data. 
The difference in the targeting efficiency between the liver and astrocyte samples was 
unexpected, but could possibly be explained by the blood brain barrier, reducing the efficacy 
of reaching the astrocytes. Also, tamoxifen is metabolized in the liver hence the 
concentration of active tamoxifen is very high. Either way, due to the development of lethal 
hepatomegaly in Aldh1l1CreERT.Becn1flox/flox mice, this model does not represent a good tool 
for assessing the role BECN1 in astrocytes. The only currently available alternative mouse 
model to target astrocytes is the GFAP-Cre model. Future studies could be approached with 
this tool, although one has to keep in mind that GFAP is also expressed by neuronal 
progenitors (Garcia, Doan et al, 2004). 
 
  





For the first time, we could show the specific mechanism of autophagy-dependent cytokine 
release in microglia in vitro. In vivo, a constitutive partial knock down of Becn1 in an AD-like 
model managed to affect the IL-1beta levels but failed to influence Abeta pathology. We are 
therefore generating a triple transgenic mouse model (APPPS1.Cx3Cr1CreERT.Becn1flox/flox 
mice) enabling the specific analysis of microglial autophagy in an AD-like mouse model.  
This new tool and the generated knowledge will support a new direction of research, to 
unravel the therapeutic potential of autophagy-dependent inflammation in 




Methods already described extensively in the paper are not repeated here.  
 
Mice  
To test the microglial-specific Becn1 deletion in the Cx3Cr1CreERT.Becn1flox/flox mice, 60-day-old 
animals were injected intraperitoneally with 75mg/kg tamoxifen diluted in olive oil, and a 
vehicle control group with just olive oil, for 5 consecutive days. To test the astrocyte-specific 
Becn1 deletion in the Aldh1l1CreERT.Becn1flox/flox mice the same treatment paradigm was 
applied. Animals were kept in individually ventilated cages with a 12 h light cycle with food 
and water ad libitum. All animal experiments were conducted in accordance with animal 
welfare acts and were approved by the regional office for health and social service in Berlin 
(LaGeSo), TVA G0251/15. 
 
Cell isolation 
Twenty days after the tamoxifen injections, we sacrificed the mice and isolated the cell 
populations of interest. From the Cx3Cr1CreERT.Becn1flox/flox mice we isolated peritoneal 
macrophages, splenocytes, intestinal macrophages and microglia. Peritoneal macrophages 
were collected by peritoneal lavage with PBS. Splenocytes were collected from a spleen 
pressed through a 70µm cell strainer, treated with red blood cell lysis buffer and the cell 
suspension was enriched for CD11b+ cells with magnetic beads (Cat. 130-093-634, Miltenyi) 
according to manufacturers protocol. In short, the cell suspension is incubated with CD11b+ 
beads, and runs over a column attached to a magnet. CD11b+ cells stick to the column, while 
all other cells flow through. Afterwards, remove the column from the magnet and flush out 
the CD11b+ cells. Intestinal macrophages are collected by tissue lysis of the small intestine 
with collagenase IV (according to (Geem, Medina-Contreras et al, 2012)) and enriched for 
CD11b+ cells with magnetic beads (Cat. 130-093-634, Miltenyi). The hemispheres are 
dissociated using the neural tissue dissociation kit (Cat. 130-092-628, Miltenyi) and enriched 
for CD11b+ cells with magnetic beads (Cat. 130-093-634, Miltenyi). Microglia purity was 
assessed by FACS before further analysis (Fig. 6).  
 






Figure 6. Purity check of microglia cell isolation with CD11b+ beads  
Flow cytometry analysis of all brain cells before sorting with CD11b magnetic beads (top two graphs) 
and all brain cells after sorting with CD11b magnetic beads (bottom two graphs) from a 450 day old 
APPPS1 mouse with well-established Abeta pathology. MACS sorting purified the cell population to 
93.6% microglia (CD11b+ CD45int) while 1.94% CNS-macrophages (CD11b+CD45hi) were found in the 
MACS sorted cell population. 
 
From the Aldh1l1CreERT.Becn1flox/flox mice we isolated astrocytes with the adult brain 
dissociation kit (Cat. 130-107-677, Miltenyi) including debris removal and red blood cell 
removal, followed by ACSA-2 magnetic beads sorting (Cat. 130-097-678, Miltenyi) over a 
column attached to a magnet. Here, the ACSA-2+ cells stick to the column, while all other 
cells flow through. Afterwards, the column is removed from the magnet and the astrocytes 
are flushed out.  
 
  




Phagocytosis assay  
We used an in vitro assay using fluorescent pHrodo E. coli bioparticles (Cat. P35361, Life 
Technologies) that are pH sensitive, and therefore emit light of a different wavelength when 
incorporated into lysosomes. The assay was performed according to the manufacturer’s 
protocol. In short, plate cells in a 96 well plate and leave overnight, next day, replace 
medium by 100 µL bioparticles in culture medium [1 mg/mL]. Incubate cells with the 
bioparticles for 1 hour in a 37C incubator without CO2. Fluorescence is measured with a 
fluorescent microplate reader (iControl software, Tecan). Auto-fluorescence is corrected by a 
medium-only control measurement. Phagocytic capacity is normalized to non-treated cells, 




To assess the deletion of exon 4-7 of the Becn1 gene specifically, we designed SybrGreen 
qPCR primers bridging exon 4 and exon 5, using the ApE software to select the respective 
DNA sequence and NCBI/Primer blast to verify the complementarity and GC balance. We 
confirmed the melting curve was clean and that the qPCR product on an electrophoresis gel 
had the expected size (116 bp). 
Primer sequences:  
Forward primer Becn1_exon4-5 ACCCGCTGTGTGAGGAATG 
Reverse primer Becn1_exon4-5 CATCTGCTCTAGGATCTCCAAACA 
 
Immunoprecipitation 
One million microglia were plated in a well of a 6 well plate and stimulated with LPS/ATP or 
not stimulated at all. These were harvested and collected as a pellet. The pellet was used to 
perform the immunoprecipitation according to the manufacturer’s protocol. In short, lyse 
the cell pellet and incubate with protein A/G agarose suspension for 3 hours. 1 hour 
incubation with the antibody followed by overnight incubation with protein A/G agarose 
suspension. Perform 5 washes with 3 different wash buffers to obtain the final protein pellet 
for western blot. A sample was taken from the lysed cell pellet before incubation with A/G 
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Beclin1-driven autophagy modulates the
inflammatory response of microglia via NLRP3
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Abstract
Alzheimer’s disease is characterized not only by extracellular
amyloid plaques and neurofibrillary tangles, but also by microglia-
mediated neuroinflammation. Recently, autophagy has been linked
to the regulation of the inflammatory response. Thus, we investi-
gated how an impairment of autophagy mediated by BECN1/
Beclin1 reduction, as described in Alzheimer’s disease patients,
would influence cytokine production of microglia. Acutely stimu-
lated microglia from Becn1+/ mice exhibited increased expression
of IL-1beta and IL-18 compared to wild-type microglia. Becn1+/
APPPS1 mice also contained enhanced IL-1beta levels. The investi-
gation of the IL-1beta/IL-18 processing pathway showed an
elevated number of cells with inflammasomes and increased levels
of NLRP3 and cleaved CASP1/Caspase1 in Becn1+/ microglia.
Super-resolation microscopy revealed a very close association of
NLRP3 aggregates and LC3-positive vesicles. Interestingly,
CALCOCO2 colocalized with NLRP3 and its downregulation
increased IL-1beta release. These data support the notion that
selective autophagy can impact microglia activation by modulating
IL-1beta and IL-18 production via NLRP3 degradation and thus
present a mechanism how impaired autophagy could contribute to
neuroinflammation in Alzheimer’s disease.
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Introduction
Alzheimer’s disease (AD) is the most common neurodegenerative
disorder. The main hallmarks of AD are extracellular amyloid
plaques (main component amyloid-beta (Abeta) peptide), neuro-
fibrillary tangles (the main component hyperphosphorylated MAP
tau), and neuroinflammation. Microglia, the resident immune cells
of the central nervous system, are involved in two aspects of AD:
removal of extracellular Abeta by phagocytosis and production and
release of cytokines resulting in progressive neuroinflammation.
Neuroinflammation correlates in many animal models with an
increase in extracellular Abeta, and microglia are regarded as the
main producers of pro-inflammatory cytokines (Heppner et al,
2015). In vivo interleukin (IL)-1 (Griffin et al, 1989), IL-6, granulo-
cyte-macrophage colony-stimulating factor (GM-CSF) (Patel et al,
2005), IL-12, and IL-23 (Vom Berg et al, 2012), as well as tumor
necrosis factor (TNF) alpha (Fillit et al, 1991), were detected in
human patients with AD or in different animal models with AD-like
pathology (Prokop et al, 2013). While enhanced neuroinflammation
is well established in the late stages of AD, recent data also suggest
a role for inflammation in the development of the disease. Injection
of double-stranded RNA (Poly:IC) into wild-type mice, thus mimick-
ing viral infection, resulted in increased IL-1beta levels followed by
an AD-like pathology at higher age (Krstic et al, 2012). Furthermore,
mouse models lacking the pro-IL-1beta processing proteins NLRP3
(NLR family, pyrin domain containing 3) or CASP1/Caspase1 show
decreased inflammation and Abeta burden and increased Abeta
phagocytosis (Heneka et al, 2013).
The mechanisms behind enhanced microglial activation and
increased cytokine release in AD seem to be diverse. Priming of
microglia by interaction with Abeta is a possibility (Heppner et al,
2015). Another or additional mechanism could be autophagy, as
recent work on myeloid cells indicates that impaired autophagy
mediates increased inflammation. Mutations in the AD risk factor
TREM2 are linked to anomalous autophagy (Ulland et al, 2017).
Loss of the autophagy protein ATG16L1 is associated with Crohn’s
disease and resulted in enhanced pro-inflammatory cytokine
production of macrophages in response to stress (Saitoh et al, 2008;
Murthy et al, 2014). A conditional knock-out of Atg5 or Atg7 in
macrophages correlated with increased severity of uveitis (Santeford
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et al, 2016), liver fibrosis (Lodder et al, 2015), or colitis (Lee et al,
2016). In vitro data on macrophages and macrophage cell lines show
that addition of the autophagy blocker 3-MA resulted in increased
IL-1beta formation (Harris et al, 2011; Zhou et al, 2011; Shi et al,
2012; de Luca et al, 2014). Data on microglia are emerging but are
somewhat controversial: Some publications describe increased acti-
vation of primary mouse microglia or the microglial cell line BV2
after knockdown of autophagy genes (Cho et al, 2014; Ye et al,
2017) or lysosomal damage by manganese (Wang et al, 2017).
Others have reported no changes in cytokine release when auto-
phagic flux was blocked for 24 h by Bafilomycin A1 (Franc¸ois et al,
2013).
Microglia isolated from human AD patients show strongly
reduced protein levels of BECN1/Beclin1 (Lucin et al, 2013). BECN1
is an essential part of the multi-protein complex that is necessary for
nucleation of the autophagic vesicle (Zhang et al, 2016). Homozy-
gous loss of Becn1 causes embryonic cell death between E7.5 and
E8.5 (Yue et al, 2003), while heterozygous loss of Becn1 mediates
decreased autophagy in different cell types (Qu et al, 2003; Pickford
et al, 2008). Furthermore, heterozygous loss of Becn1 in an AD
mouse model (T41 APP+/ mice) resulted in increased Abeta
burden (Pickford et al, 2008). In addition, BECN1 was shown to be
involved in receptor recycling and retromer recruitment in phago-
cytosis of Abeta in vitro (Lucin et al, 2013).
Based on these data, we envision a central role for microglial
BECN1 in the regulation of neuroinflammation.
Results
Reduction in BECN1 and impairment of autophagy results in
enhanced IL-1beta and IL-18 release from microglia
To investigate whether modulation of BECN1 levels in microglia
influences neuroinflammatory responses, Becn1+/ mice were
chosen as a model system with reduced BECN1 levels. The use of
Becn1 heterozygous mice was necessary since Becn1/ mice die in
utero before the microglia precursor cells leave the yolk sac to colo-
nize the developing brain (Yue et al, 2003). Microglia were isolated
from newborn Becn1+/ and wild-type mouse pups. The BECN1
content of microglia from Becn1+/ and wild-type mice was
assessed by Western blotting: Microglia from Becn1+/ mice show
around 50% reduction in BECN1 protein compared to microglia
from wild-type mice (Fig 1A). Next, the effect of BECN1 reduction
on autophagy was determined. Microglia were kept for 2 h either in
cultivation medium (DMEM with 10% FCS) or in amino acid-free
starvation medium (HBSS), in the presence or absence of Bafilo-
mycin A1. While the HBSS-cultured microglia showed a trend of
decreased autophagic flux in the Bafilomycin A1-treated Becn1+/
microglia, LC3-II/MAP1LC3B-II levels of Becn1+/ microglia were
significantly lower when autophagic flux was blocked with Bafilo-
mycin A1 in medium-exposed cells, in accordance with the reduced
BECN1 content (Fig 1B). Staining of endogenous LC3-positive vesi-
cles in Bafilomycin A1-treated microglia supports these data
(Fig 1C).
To determine the effect of BECN1 and autophagy reduction on
inflammation, microglia were treated with a standard acute
pro-inflammatory stimulus: Cells were subjected for 3 h to LPS
(1 lg/ml) followed by 45 min of ATP (1 mM). To quantify the
release of pro-inflammatory cytokines, AD-relevant cytokines
IL-1beta, IL-18, TNFalpha, and IL-6 were measured by ELISA.
Reduction in BECN1 resulted in an increased presence of IL-1beta
and IL-18 in the supernatant of LPS/ATP-stimulated Becn1+/
microglia compared to the supernatant of LPS/ATP-stimulated wild-
type microglia (Fig 2A and B). Increased IL-1beta levels were also
detected in the supernatant of Becn1+/ microglia by Western blot
(Fig EV1A). In contrast, levels of TNFalpha and IL-6 were not
altered (Fig EV1B).
Subsequently, we sought to confirm these data by a pharmaco-
logical approach: Microglia isolated from wild-type mouse pups
were treated with the pro-inflammatory stimulus in growth medium
with 10% FCS or in amino acid-free starvation medium HBSS.
IL-1beta release after stimulation with LPS/ATP was significantly
lower in cells kept in HBSS (Fig 2C). Furthermore, wild-type micro-
glia in full medium or HBSS were stimulated with LPS and ATP in
the presence or absence of the autophagy blocker 3-Methyladenine
(3-MA). Short-term treatment of 3-MA for 1 h 45 min resulted in
reduction in LC3-positive vesicles (Fig 2D) and in a significant
increase in IL-1beta (Fig 2C). While cells kept in HBSS released less
cytokines in general, TNFalpha release was decreased upon 3-MA
treatment in growth medium as well as in HBSS medium, whereas
the IL-6 release was not affected by 3-MA treatment (Fig EV1C).
To investigate whether reduced BECN1 levels also have an effect
on inflammation in vivo, we crossed Becn1+/ mice to APPPS1
mice. APPPS1 mice are an established AD model with progressive
amyloid-beta pathology and corresponding neuroinflammation
(Radde et al, 2006). APPPS1 Becn1+/ mice were analyzed at
3 months (amyloid-beta deposits detectable in the brain), 4 months
▸Figure 1. Autophagy is impaired in Becn1+/ microglia.A BECN1 expression of microglia from Becn1+/ and wild-type mouse pups in full medium without Bafilomycin A1 (Baf) was quantified by Western blotting. Microglia
from Becn1+/ mice show a significant reduction in BECN1 (48%) compared to microglia from wild-type mice; mean  SEM, wild-type n = 3, Becn1+/ n = 7; two-
tailed t-test **P < 0.01. Blot shows representative amounts of BECN1 after various treatments.
B Microglia from newborn Becn1+/ and wild-type mouse pups were kept for 2 h either in full medium or in HBSS with or without Bafilomycin A1 (Baf). LC3 and ACTIN
levels were determined by Western blot. LC3-II was significantly reduced in microglia from Becn1+/ mice after Baf treatment in full medium compared to wild-type
microglia; mean  SEM, wild-type n = 3, Becn1+/ n = 4; two-tailed t-test *P < 0.05.
C Microglia from newborn Becn1+/ and wild-type mouse pups were kept for 2 h either in full medium or HBSS with Bafilomycin A1 (Baf) and stained for endogenous
LC3. Exemplary images and the quantification of LC3-positive vesicles/lm2 cell area show reduced presence of LC3-positive vesicles in microglia from Becn1+/ mice
and induction of autophagy by HBSS; mean  SEM, wild-type n = 4, Becn1+/ n = 4, 3–5 fields per view/n and condition and 73–271 cells/n and condition; two-tailed
t-test *P < 0.05; scale bar: 20 lm.
Source data are available online for this figure.
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(plaque formation), and 8 months (full plaque pathology and cogni-
tive deficits) and compared to age-matched wild-type, Becn1+/ and
APPPS1 mice. The brains were processed in different buffers, result-
ing in four fractions containing proteins with different solubility
(Kawarabayashi et al, 2001). The content of pro-inflammatory
cytokines in the fractions containing highly soluble proteins (TBS
and TX fraction) was analyzed by electrochemiluminescence
(Meso Scale). While 3-month-old mice showed similar levels of IL-
1beta regardless of the genotype, brain lysates of 4- and 8-month-
old APPPS1 Becn1+/ mice contained significantly more IL-1beta in
both fractions (Fig 2E). In contrast, TNFalpha was not altered at all
and IL-6 was only increased in the TX fraction but not the TBS frac-
tion of 8-month-old APPPS1 Becn1+/ mice (Fig EV1D and E).
To determine whether an increase in IL-1beta expression in
APPPS1 Becn1+/ mice may affect amyloid-beta pathology, we
quantified the amount of amyloid-beta 1–40 and amyloid-beta 1–42
in protein lysates of brains from age-matched APPPS1 and APPPS1
Becn1+/ 3-, 4-, and 8-month-old mice by means of Meso Scale
(Fig 2F) as well as by morphometric analyses of immunostained
histological sections from brains of 4-month-old mice (Fig EV2A–C).
Since we were not able to detect a significant difference in amyloid
burden as well as in plaque size and plaque distribution in APPPS1
versus APPPS1 Becn1+/ mice (Figs 2F and EV2A–C), we compared
the phagocytic capacity of microglia in acute brain slices from 4-
month-old Becn1+/ mice to those of microglia from wild-type mice.
Again, no significant differences with respect to the amount of
phagocytic cells or the overall phagocytic index became apparent
(Fig EV2D–F). Taken together, these data demonstrate that reducing
BECN1 and, thus, a diminution in autophagy increased specifically
the release of IL-1beta and IL-18 from acute activated (LPS/ATP)
and primed (amyloid-beta) microglia in vitro and in vivo, but did not
substantially alter amyloid-beta pathology or phagocytosis in vivo.
Reduction in BECN1 influences the IL-1beta and IL-18
processing pathway
In order to assess the mechanism by which BECN1 is influencing
IL-1beta and IL-18 production and/or release, we investigated the
crucial steps in the common pathway of IL-1beta and IL-18 produc-
tion. The pro-inflammatory response starts with transcription and
translation of the IL-1beta and IL-18 precursors followed by their
processing at the inflammasome (Walsh et al, 2014). Therefore,
microglia isolated from newborn Becn1+/ and wild-type mouse
pups were stimulated with LPS and ATP and the levels of pro-IL-
1beta protein were determined by Western blotting. No differences
in the levels of pro-IL-1beta were discernible (Fig EV3A).
Subsequently, the formation and assembly of the inflammasome,
the protein complex responsible for processing pro-IL-1beta to IL-
1beta by CASP1, were analyzed. The protein levels of NLRP3, the
sensor component of the inflammasome, were analyzed by Western
blotting in Becn1+/ and wild-type microglia. While non treated
cells expressed only low levels of NLRP3, stimulation with LPS/ATP
increased NLRP3 expression strongly and activated microglia of
Becn1+/ mice contained significantly more NLRP3 than microglia
of wild-type mice (Fig 3A). In contrast, no difference between the
Nlrp3 mRNA levels of Becn1+/ and wild-type microglia was appar-
ent (Fig 3B).
Next, inflammasome assembly was investigated by staining of
ASC (apoptosis-associated speck-like protein containing a carboxy-
terminal CARD), the adaptor protein for pro-CASP1 binding and
processing. Again, microglia isolated from newborn Becn1+/ and
wild-type mouse pups were stimulated with LPS and ATP or left
untreated. In non treated cells, ASC showed diffuse staining in the
cytoplasm (Fig 3C). However, after stimulation, formation of
inflammasomes could be observed in a subpopulation of cells, as
well as release of inflammasomes after pyroptosis/ejection (Baroja-
Mazo et al, 2014; Franklin et al, 2014). Quantification of these ASC
foci in stimulated cells showed an almost threefold increased pres-
ence of inflammasomes in or around Becn1+/ microglia (Fig 3C).
Finally, pro-CASP1 as substrate for the inflammasome and the
processed, active CASP1 was analyzed. Pro-CASP1 protein levels in
cell lysates of LPS/ATP-stimulated microglia showed no difference
between Becn1+/ and wild-type cells (Fig EV3B). However,
Western blotting of the cell supernatant from stimulated microglia
revealed that a significantly higher amount of cleaved, active CASP1
p10 was released from Becn1+/ microglia compared to wild-type
▸Figure 2. Reduction in BECN1 results in enhanced IL-1beta and IL-18 release.A, B Microglia isolated from newborn Becn1+/ and wild-type mouse pups were either non treated or treated with a pro-inflammatory stimulus (LPS followed by ATP). As
additional controls, cells treated only with LPS or ATP were used in (A). The concentration of the pro-inflammatory cytokines IL-1beta (A) and IL-18 (B) in the cell
supernatant was determined by ELISA. Reduction in BECN1 significantly enhanced release of both cytokines after stimulation with LPS/ATP; mean  SEM, wild-type
n (A/B) = 9/2, wild-type LPS n = 3/0, wild-type ATP n = 3/0, wild-type LPS/ATP n = 9/9, Becn1+/ n = 23/5, Becn1+/ LPS/ATP n = 23/23, two-tailed t-test *P < 0.05.
C Microglia isolated from wild-type mouse pups were pre-incubated in full medium or starvation medium HBSS before addition of a pro-inflammatory stimulus (LPS
followed by ATP). The autophagy blocker 3-MA was added for the final 1 h 45 min of the experiment. The concentration of the pro-inflammatory cytokine IL-1beta
in the cell supernatant was determined by ELISA. Incubation with HBSS reduced IL-1beta release significantly while 3-MA treatment increased it; mean  SEM, full
medium n = 6, full medium LPS/ATP n = 6, full medium LPS/ATP + 3-MA n = 3, HBSS n = 6, HBSS LPS/ATP n = 6, HBSS LPS/ATP + 3-MA n = 6; two-tailed t-test
*P < 0.05; **P < 0.01.
D Microglia isolated from wild-type mouse pups were pre-incubated in starvation medium HBSS before addition of a pro-inflammatory stimulus (LPS followed by
ATP). The autophagy blocker 3-MA was added for the final 1 h 45 min of the experiment, microglia were stained for LC3, and images were taken by confocal
microscopy. Representative images show a reduction in LC3-positive vesicles in 3-MA-treated cells. Scale bar: 20 lm.
E Proteins were extracted from brains of wild-type, Becn1+/, APPPS1, and APPPS1 Becn1+/ mice at the indicated ages. IL-1beta was measured by
electrochemiluminescence (Meso Scale) and compared within the respective age groups. IL-1beta was significantly increased in the TBS and TX fraction;
mean  SEM, wild-type: n (per age group) = 2/6/3, Becn1+/: n = 2/5/2, APPPS1: n = 5/5/6, APPPS1 Becn1+/: n = 7/9/6; ANOVA with Dunnett’s post hoc test with WT
as control group; *P < 0.05; **P < 0.01.
F Proteins were extracted from brains of APPPS1 and of APPPS1 Becn1+/ mice at the indicated ages. Amyloid-beta 1-40 and 1-42 were measured by
electrochemiluminescence (Meso Scale) and compared within the respective age groups. No difference in the amyloid-beta load between the genotypes is
apparent; mean  SEM, APPPS1: n = 5/5/6, APPPS1 Becn1+/: n = 7/9/6; ANOVA with Dunnett’s post hoc test with APPPS1 as control group, ns.
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microglia (Fig 3D). In addition, 3-MA treatment of wild-type micro-
glia significantly increased the CASP1 p10 levels in the cell super-
natant (Fig EV3C).
Taken together, these data indicate that the increase in IL-1beta
and IL-18 production in Becn1+/ microglia is linked to an upregu-
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NLRP3 is a substrate for autophagy
To determine the molecular mechanism of the effects described
above, we assessed in detail how reduced BECN1 could mediate the
observed increase in NLRP3 and inflammasomes in Becn1+/
microglia. To obtain a comprehensive impression of NLRP3 appear-
ance, and spatial distribution, endogenous NLRP3 was analyzed by
immunocytochemistry. Non treated microglia showed, in correlation
to their weak band in the Western blot, a diffuse cytoplasmic
staining with a few small NLRP3 puncta (Fig 4A). Stimulation of
microglia with LPS/ATP resulted in the emergence of more and
larger NLRP3 puncta/specs of different sizes (Fig 4A, arrows), indi-
cating formation of NLRP3 oligomers or aggregates (Susjan et al,
2017) (see also Discussion). Quantification of NLRP3 aggregates in
Becn1+/ and wild-type microglia showed a higher number of
NLRP3 aggregates in Becn1+/ microglia (Fig EV4A). These data
are in agreement with the NLRP3 protein levels quantified by
Western blotting (Fig 3A). The subcellular localization as
A B
C D
Figure 3. Reduction in BECN1 influences the IL-1beta processing pathway.
A The expression of NLRP3 protein in non treated and LPS/ATP-treated wild-type and Becn1+/ microglia was determined by Western blot and normalized to ACTIN.
Reduction in BECN1 significantly enhanced expression of NLRP3; mean  SEM, wild-type n = 4, wild-type LPS/ATP n = 9, Becn1+/ n = 4, Becn1+/ LPS/ATP n = 23;
ANOVA with Tukey’s post hoc test *P < 0.05.
B The expression of Nlrp3 mRNA in non treated and LPS/ATP-treated wild-type and Becn1+/ microglia was determined by qPCR. No significant differences can be
detected between wild-type and Becn1+/ microglia; mean  SEM, wild-type: n = 7, Becn1+/: n = 3; ANOVA with Tukey’s post hoc test, ns for LPS/ATP-treated wild-
type versus Becn1+/.
C LPS/ATP-treated and non treated wild-type and Becn1+/ microglia were immunolabeled for ASC (red) and imaged by confocal microscopy to investigate the assembly
of inflammasomes. In non-stimulated cells, ASC is distributed diffusely in the cytoplasm (upper panels). However, after stimulation, formation of inflammasomes
(arrowheads) can be detected in a subpopulation of cells as well as release of inflammasomes after pyroptosis/ejection (arrow). Quantification showed a significantly
increased percentage of inflammasomes in or around Becn1+/ microglia; mean  SEM, wild-type LPS/ATP n = 4, Becn1+/ LPS/ATP n = 7; two-tailed t-test *P < 0.05;
scale bar: 50 lm, insert scale bar: 10 lm.
D The presence of cleaved CASP1 (p10) protein in the supernatant of LPS/ATP-treated wild-type and Becn1+/ microglia was determined by Western blot and
normalized to ACTIN. Reduction in BECN1 significantly enhanced release of CASP1; mean  SEM, wild-type LPS/ATP n = 8, Becn1+/ LPS/ATP n = 18; two-tailed t-test
*P < 0.05.
Source data are available online for this figure.
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determined by the 3-dimensional distance of NLRP3 aggregates to
the nucleus did not differ between Becn1+/ and wild-type micro-
glia (Fig EV4B). To confirm the specificity of the NLRP3 staining,
stimulated microglia were co-labeled with ASC. As described previ-
ously (Walsh et al, 2014), we observed a very close association and
partial overlap of NLRP3 and ASC signals using confocal and super-
resolution microscopy (Fig EV4C and D).
To investigate the fate of the NLRP3 puncta/aggregates, microglia
from Becn1+/ and wild-type mouse pups were treated with LPS and
ATP (alongside non treated controls) and then stained for endogenous
NLRP3 and LC3. Confocal microscopy of non treated cells showed
only a few overlapping signals of LC3-stained vesicles (arrowheads)
and small NLRP3 puncta (arrows) (Fig 4A). However, stimulated
microglia contained many LC3-positive vesicles that strongly colocal-
ized with NLRP3 aggregates of different sizes (Fig 4A). These colocal-
izations appeared in both Becn1+/ and wild-type microglia,
indicating engulfment and probable degradation of NLRP3 by
autophagosomes. As NLRP3 has been shown to colocalize with mito-
chondria (Zhou et al, 2011; Subramanian et al, 2013; Bracey et al,
2014), the localization of MTR-stained mitochondria, NLRP3, and LC3
was determined by confocal microscopy of LPS/ATP-stimulated cells.
NLRP3 was found to colocalize not only with LC3, but also with MTR-
stained mitochondria, and NLRP3 aggregates/puncta were in addition
detectable in close vicinity to mitochondria though not directly colo-
calizing. A colocalization of NLRP3, LC3, and mitochondria was,
however, not observed (Fig EV4E).
To gain a deeper understanding of the interaction of NLRP3 and
autophagosomes, we performed 3D structured illumination micro-
scopy (SIM), a super-resolution microscopy method that increases the
conventional spatial resolution (i.e., confocal) by factor 2 in all three
dimensions. SIM and subsequent 3D volume rendering of large (I) and
small (II) NLRP3 aggregates showed indeed that LC3-positive struc-
tures corral around and partially overlap with the NLRP3 clusters in
wild-type (Fig 4B) and Becn1+/ microglia (Appendix Fig S1A, see
also Appendix videos of 3D projections). In order to confirm that
NLRP3 clusters really present a substrate for autophagy, we quantified
the colocalization of NLRP3 and LC3 by performing 3D radial intensity
profiles around the center of NLRP3 clusters (Figs 4C and 5D). Indeed,
both proteins colocalized to the same organelle as indicated by an
overlap of both maxima in the radial intensity profile. The signal
decay within the known size of autophagosomes (Mizushima et al,
2002) indicates that NLRP3 aggregates were indeed engulfed/taken up
by the LC3-positive vesicles (Fig 4C, Appendix Fig S1B and C).
To assess whether NLRP3 aggregates exist also in microglia of
adult mice, an ex vivo approach was employed: Microglia were
isolated from 8-month-old wild-type and APPPS1 mice and culti-
vated for 4 h. Subsequent confocal microscopy revealed NLRP3
aggregates as well as LC3-positive vesicles inside these cells.
Furthermore, some NLRP3 signals colocalized with LC3, further
supporting the conclusion that NLRP3 degradation occurs through
autophagy (Fig EV5A). In contrast to microglia, neonatal murine
astrocytes as yet another cytokine-producing brain cell did not
contain NLRP3 (Fig EV5B and C).
CALCOCO2/NDP52 colocalizes with NLRP3 and modulates
IL-1beta release
In order to determine the interaction between NLRP3 and the vesicles
on the molecular level, we investigated possible adaptor proteins.
p62/SQSTM1 has been described as an adaptor protein for the autop-
hagic removal of inflammasomes (Shi et al, 2012). Therefore, we
stained NLRP3 and p62 in LPS/ATP-treated but detected no colocal-
ization (Appendix Fig S2A). In contrast, CALCOCO2/NDP52 (arrow-
heads) which acts as an autophagic adaptor protein in human cells
colocalized with smaller and larger NLRP3 aggregates (arrows) in
LPS/ATP stimulated wild-type microglia (Fig 5A). SIM confirmed that
both proteins were in very close proximity (Fig 5B); the same could
also be shown for LPS/ATP-treated Becn1+/ microglia (Appendix Fig
S2B). The colocalization of NLRP3 and CALCOCO2 was confirmed by
performing 3D radial intensity profiles on NLRP3 clusters in wild-type
(Fig 5C) and Becn1+/ microglia (Appendix Fig S2C). To further
substantiate this interaction and to investigate the location of both
proteins within the autophagosome, we used the SIM images from
wild-type microglia and compared the LC3 and CALCOCO2 signal in
the center of NLRP3 clusters with its maximal intensity within the
cluster. Clearly, the relative center intensity of CALCOCO2 (~95%)
was significantly higher than the center intensity of LC3 (~60%)
(Fig 5D). These data strongly suggest that NLRP3 interacts with
CALCOCO2 within the lumen of autophagosomes, while LC3 is local-
ized to both sides of the autophagosomal membrane.
Murine cells express a truncated form of CALCOCO2 contain-
ing the SKICH, LIR, and coiled-coil domain but not the ubiquitin-
binding and galectin-8 domains (Tumbarello et al, 2015). To
determine whether the close localization of murine CALCOCO2 to
NLRP3 may have a functional impact and is related to cytokine
production, microglia were treated with a CALCOCO2 siRNA,
which resulted in significant reduction in the protein (Fig 5E).
After LPS/ATP stimulation, cells with CALCOCO2 knockdown
released more IL-1beta into the supernatant (Fig 5F), while
TNFalpha and IL-6 levels remained unchanged (Fig EV5D and E)
compared to microglia transfected with a scrambled siRNA. These
data support the idea that CALCOCO2 binds NLRP3 most proba-
bly via the SKICH domain (see Discussion) and is involved in the
modulation of IL-1beta response.
▸Figure 4. NLRP3 and LC3-positive vesicles are closely associated.A LPS/ATP-treated and non treated wild-type and Becn1+/ microglia were immunolabeled for NLRP3 (green) and LC3 (red) and imaged by confocal microscopy.
Stimulation resulted in the appearance of many NLRP3-containing aggregates of different sizes (arrows). In non treated cells, only a few overlapping signals with LC3-
stained autophagosomes (arrowheads) are visible. Stimulated microglia, however, showed multiple colocalizations of LC3-positive vesicles and NLRP3 aggregates;
scale bar: 7.5 lm.
B LPS/ATP-treated wild-type microglia were immunolabeled for NLRP3 (green) and LC3 (red) and analyzed by super-resolation microscopy (SIM). NLRP3 aggregates of
different sizes coclustering with LC3-positive autophagosomes are clearly visible. 3D volume rendering of large (I) and small (II) NLRP3 aggregates from the magnified
ROIs showed engulfment of NLRP3 by autophagosomes; scale bar: 10 lm; magnified ROIs: 1 lm.
C 3D radial intensity profiles of NLRP3 and LC3 signals derived from SIM images in wild-type microglia, centered on the maxima of NLRP3 clusters. The radial profiles
confirm that both proteins colocalize to the same organelle; mean  SEM, n = 4.
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Discussion
In this study, we analyzed the effects of reduced BECN1 levels on
the inflammatory process in microglia in vitro after an acute
pro-inflammatory stimulus and in vivo in an AD-like mouse model
with amyloid-beta pathology and neuroinflammation. Impaired
autophagy has been linked to AD in various ways as detailed in
recent reviews (Menzies et al, 2015, 2017), but research until now
has concentrated almost exclusively on neurons. However, neuroin-
flammation is an important driver of AD (Heppner et al, 2015), and
since microglia are the main producers of pro-inflammatory cytoki-
nes in the brain, they are in the center of interest when investigating
neuroinflammation. BECN1 is a key protein of the autophagic path-
way, and its reduction in Becn1+/ mice resulted accordingly in
diminished autophagic flux and autophagosome formation. This is
in agreement with reports demonstrating reduced autophagy in
neurons, muscle, and endothelial cells isolated from Becn1+/ mice
(Qu et al, 2003; Pickford et al, 2008), which further indicates that
microglial BECN1 reduction impairs autophagy. Becn1/ microglia
could not be employed in this study since Becn1/ embryos die in
utero very early between E7.5 and E8.5 (Yue et al, 2003), thus at a
time point before microglia precursors leave the yolk sac to colonize
the developing brain (starting at E9.5) (Ginhoux et al, 2010;
Swinnen et al, 2013; Tay et al, 2017).
In vitro genetic reduction in Becn1 or addition of the autophagy
blocker 3-MA resulted in increased expression of IL-1beta and IL-18
after addition of a standard acute pro-inflammatory stimulus (LPS
followed by ATP), while TNFalpha or IL-6 was not altered. The
specific targeting of the IL-1beta/IL-18 pathway by impaired auto-
phagy is in agreement with previous data showing no effect on
TNFalpha release after knockdown of Atg7 in neonatal microglia
(Cho et al, 2014). In contrast, Ye et al (2017) observed not only
enhanced IL-1beta levels, but also an increase in TNFalpha and IL-6
after impairment of autophagy by 3-MA, or after knockdown of
Becn1 or Atg5 in the microglial cell line BV2. Additionally, Santeford
et al (2016) also described enhanced IL-6 levels after loss of Atg5. A
recent analysis of microglia from different origins revealed that the
expression profile of primary microglia differs from BV2 cells, where
neonatal primary microglia resemble adult microglia more closely
than BV2 cells, which could account for the different findings
(Butovsky et al, 2014). Also, macrophages with loss of Atg16l1
exhibited a specific increase in IL-1beta/IL-18 production and
showed no effect on TNFalpha or IL-6 production (Saitoh et al,
2008). Based on these data, we conclude that the observed increase
in IL-1beta/IL-18 production in Becn1+/ microglia is not caused by
a general microglial priming and activation mediated by impaired
autophagy, but rather a specific intervention of the IL-1beta/IL-18
processing pathway.
To support this hypothesis, we analyzed whether reduction in
BECN1 also increased IL-1beta levels in vivo in an Alzheimer-like
setting using the established amyloid pathology model APPPS1
(Radde et al, 2006). Production of IL-1beta in microglia occurs
in vivo only after priming (Perry & Holmes, 2014) and the Il1b gene
is upregulated in primed microglia of APPPS1 mice, as well as in
acutely LPS-activated microglia as shown in a differential transcrip-
tome analysis (Holtman et al, 2015). Heterozygous loss of Becn1
alone did not result in increased IL-1beta protein levels in the brain
compared to age-matched wild-type mice. As the oldest analyzed
mice were only 8 months old, an aging-mediated effect had appar-
ently not yet occurred. However, it could be possible that older mice
show an impact of Becn1 heterozygosity, as 24-month-old mice
exhibited an upregulation of Il1b (Holtman et al, 2015).
In support of this hypothesis, we observed a significant age-
dependent upregulation of IL-1beta in TBS and TX protein fractions
from the brains from 4- and 8-month-old APPPS1 Becn1+/ mice.
Thus, when microglia were primed by extracellular amyloid-beta,
the reduced levels of BECN1 mediated an increase in IL-1beta
production. In vitro, this was an IL-1beta specific effect, as no
changes in TNFalpha were observed. However, the impact of
BECN1 reduction on IL-6 remains unclear. While no effect on IL-6
release was observed in vitro and in vivo in the TBS fraction, an
increase in IL-6 in the TX fraction of 8-month-old APPPS1 Becn1+/
mice became apparent, warranting further investigation.
In APPPS1 Becn1+/ mice, neither changes in the amyloid-beta
load were detected nor phagocytosis was altered. On first sight, this
appears to be in contrast to data from Pickford et al (2008), who
observed an increase in amyloid pathology in 9-month-old T41APP
Becn1+/ mice. However, this difference can be explained by the
fact that another transgenic mouse strains were used in our experi-
ments, particularly by the strong impact of the two overexpressed
transgenes APP and PS1 in APPPS1 mice used herein. Knockdown of
Becn1 in BV2 microglial cells has been shown to reduce
▸Figure 5. CALCOCO2/NDP52 colocalizes with NLRP3 and modulates IL-1beta release.A LPS/ATP-treated wild-type microglia were stained for NLRP3 (green) and CALCOCO2 (red) and analyzed by confocal microscopy. Colocalizations of NLRP3 aggregates
(arrows) and CALCOCO2 (arrowheads) are apparent; scale bar: 10 lm.
B LPS/ATP-treated wild-type microglia were stained for NLRP3 (green) and CALCOCO2 (red) and analyzed by super-resolation microscopy (SIM). NLRP3 aggregates
coclustering with CALCOCO2-positive signals are visible. 3D volume rendering of NLRP3 aggregates from the magnified ROIs showed close contact of NLRP3 with
CALCOCO2; scale bar: 10 lm; magnified ROIs: 1 lm.
C 3D Radial intensity profiles of NLRP3 and CALCOCO2 signals derived from SIM images in wild-type microglia, centered on the maxima of NLRP3 clusters. The radial
profiles confirm that both proteins colocalize; mean  SEM, n = 3.
D In SIM images from wild-type microglia the subautophagosomal localization of LC3 and CALCOCO2 was analyzed in relation to NLRP3. LC3 and CALCOCO2 intensities
at the center of NLRP3 aggregates were normalized to their maximum within the same cluster. While CALCOCO2 intensity is near maximal at the center of NLRP3
aggregates (indicating the lumenal localization of CALCOCO2), the relative LC3 intensity was significantly lower (in agreement with the LC3 localization at
autophagosomal membranes); LC3: n = 4, CALCOCO2: n = 3; two-tailed t-test **P < 0.01.
E Microglia from Becn1+/ mice were transfected with scrambled siRNA or with siRNA for CALCOCO2. 6 d after transfection, cells were stimulated with LPS/ATP. The
expression of CALCOCO2 protein was determined by Western blot. Application of CALCOCO2 siRNA resulted in significantly reduced expression of CALCOCO2;
mean  SEM, n = 3; two-tailed t-test *P < 0.05.
F The amount of IL-1beta in the supernatant released from the cells described in (E) was determined by ELISA. Microglia with a CALCOCO2 knockdown released
significantly more IL-1beta; mean  SEM, n = 3; two-tailed t-test *P < 0.05.
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phagocytosis (Lucin et al, 2013), while an increase in IL-1beta
expression is supposed to augment the phagocytic activity (Ferreira
et al, 2011). While the lack of a difference in phagocytosis in
APPPS1 Becn1+/ microglia certainly explains why there is no
substantial difference in amyloid-beta burden in APPPS1 mice with
one versus two alleles of Becn1, it appeared to be counter-intuitive
at first sight, also in light of previous data showing that IL-1beta
release can drive the phagocytic capacity of microglia. However and
importantly, Lucin et al (2013) demonstrated that knocking down
Beclin1 in BV2 microglial cells reduces the phagocytic capacity of
these cells. Based on this, we assume that the Beclin1-mediated
decrease in phagocytosis, which should also apply to Becn1+/
microglia, may be compensated by the IL-1beta-driven reverse
effect, that is, that in heterozygous Becn1+/ microglia these oppos-
ing effects modulating phagocytosis outcompete each other. Along
this line, one would speculate that APPPS1 mice with a homozygous
deletion of Beclin1 are expected to harbor microglia with reduced
phagocytic microglia, supposedly resulting in an increase in amyloid
pathology. The respective experimental in vivo proof of this hypoth-
esis is, however, difficult to provide given that homozygous Beclin1
knock-out mice are lethal (Qu et al, 2003; Yue et al, 2003). Future
studies, perhaps with older mice, may answer this question. Alter-
natively, a microglia-targeted complete loss of BECN1 by using a
Becn1flox/flox mouse crossed to a Cx3cr1Cre or Sall1Cre mouse could
maximize the effects shown here.
A fundamental question is the mechanism by which reduced
BECN1 levels and autophagy modulate the IL-1beta/IL-18 produc-
tion. Proposed mechanisms include degradation of pro-IL-1beta
(Harris et al, 2011), degradation of inflammasomes (Shi et al,
2012), and an indirect activation of the inflammasome via accumu-
lation of dysfunctional mitochondria and oxidative stress due to
impaired mitophagy (Saitoh et al, 2008; Zhou et al, 2011; Lodder
et al, 2015; Lee et al, 2016; Ye et al, 2017). Since no significant
changes in pro-IL-1beta levels were observed, we investigated other
steps in the IL-1beta/IL-18 processing pathway. Here, increased
levels of NLRP3 and cleaved CASP1 alongside a higher percentage
of cells with ASC-stained inflammasomes were detected. Pro-CASP1
is cleaved into p10 and p20 fragments, which were reported to be
degraded via the ubiquitin–proteasome system (Squires et al, 2007;
Muehlbauer et al, 2010; Van Opdenbosch et al, 2014). Therefore,
SIM was used as a super-resolation microscopy method to deter-
mine the fate of NLRP3 and the inflammasomes. Staining of endoge-
nous NLRP3 in LPS/ATP-stimulated microglia revealed several
distinct, highly fluorescent NLRP3 puncta/specs in addition to a
rather diffuse cytoplasmic staining, which was also observed in non
treated cells. The specificity of the NLRP3 staining was confirmed
using SIM by co-staining with ASC: An intimate contact between
NLRP3 and ASC in activated cells could be observed. Structurally,
this interaction resembled the NLRP3-ASC interaction observed in
the Salmonella-induced inflammasome (Man et al, 2014), where
ASC is forming a ring-like scaffold for NLRP3. One apparent dif-
ference is the presence of two or more intervened ASC rings in the
inflammasome of LSP/ATP-stimulated microglia, which is not seen
in Salmonella-induced inflammasome activation.
The co-staining of endogenous LC3 and NLRP3 revealed numer-
ous colocalizations of both signals. This correlates with data of
Chuang et al (2013) that showed colocalization of overexpressed
and fluorescence-tagged LC3 and NLRP3 in HEK293 cells.
Stimulated myeloid cells normally contain only one or two ASC-
containing inflammasomes (Baroja-Mazo et al, 2014; Franklin et al,
2014) (see also Fig 3C) that are also significantly larger than most of
the NLRP3 signals seen in these cells (see Fig EV4C and D). Murine
NLRP3 has a calculated molecular weight of 113 kDa and the pyrin
domain has to exist at least as a trimer to trigger IL-1beta produc-
tion, which is apparently independent of the formation of ASC-
containing inflammasome (Susjan et al, 2017). Thus, it seems plau-
sible that the observed smaller NLRP3 aggregates present NLRP3
trimers or higher oligomeric forms as suggested for NLRP2 (Faustin
et al, 2007) or NLRC4 (Hu et al, 2015; Zhang et al, 2015). The large
NLRP3-positive aggregates are likely part of a completely assem-
bled, ASC-containing inflammasome. NLRP3 colocalized with mito-
chondria as shown before (Zhou et al, 2011; Subramanian et al,
2013; Bracey et al, 2014), whereas we could not observe a colocal-
ization of NLRP3, mitochondria, and LC3, indicating that mitochon-
dria are not involved in the degradation of NLRP3, or that NLRP3
has no substantial impact on mitophagy, respectively.
SIM pictures of small and large NLRP3 aggregates confirmed the
localization of NLRP3 to LC3-positive autophagosomes. The
described adaptor protein for the autophagic removal of inflamma-
somes, p62/SQSTM1 (Shi et al, 2012), did not colocalize with or
bind to NLRP3. In contrast, CALCOCO2 interacted directly with
NLRP3 and was located significantly nearer to NLRP3 than LC3 in
the SIM images. CALCOCO2 has been shown to be involved in mito-
phagy (Moore & Holzbaur, 2016) and xenophagy (Verlhac et al,
2015) in human cells. Murine cells express only a truncated version
of CALCOCO2 and its functionality is under discussion. However,
the murine protein still contains the SKICH and LIR domain and
several domain-specific knock-out studies in CALCOCO2 showed
that the SKICH domain is essential for binding TRIF, TRAF6
(Inomata et al, 2012), phosphorylated tau, amyloid-beta (Jo et al,
2014), and damaged mitochondria (Furuya et al, 2018). The LIR
domain specifically binds LC3C on the autophagosomal membrane,
which then attracts all other ATG8 orthologues (von Muhlinen et al,
2013). Our data show that CALCOCO2 is located between NLRP3
and LC3 in a vesicle resembling the size of an autophagosome.
While it appears that murine CALCOCO2 is able to bind NLRP3 via
its SKICH domain, it is not yet entirely solved whether it acts as an
autophagic adaptor protein by also binding LC3, or whether addi-
tional proteins are involved in the degradation process to compen-
sate for the missing ubiquitin-binding domain. However, the
downregulation of CALCOCO2 by siRNA in microglia resulted in an
increase in IL-1beta expression, while TNFalpha and IL-6 were not
affected, implying that murine CALCOCO2, despite its truncation, is
involved in regulating IL-1beta production in murine microglia.
Materials and Methods
Mice
APPPS1+/ mice were described before (Radde et al, 2006). Male
APPPS1+/ mice were crossed to female Bl6J mice, and APPPS1+/
mice were compared to littermate wild-type controls. Becn1+/ mice
have also been described before (Qu et al, 2003) and were a gift
from Tony Wyss-Coray (Stanford University School of Medicine/
USA). Mice were bred from heterozygous matings. Becn1+/ mice
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were compared to littermate wild-type controls. Animals were kept
in individually ventilated cages with a 12-h light cycle with food
and water ad libitum. All animal experiments were conducted in
accordance with animal welfare acts and were approved by the
regional office for health and social service in Berlin (LaGeSo).
Microglia isolation and culture
Newborn animals (2–4 days) were killed by decapitation. The
meninges were removed, and the brain was homogenized. Cells were
separated by incubation with 0.1% trypsin for 15 min at 37°C. Cells
were cultivated at 37°C with 5% CO2 and 95% air in DMEM (41966-
029, Invitrogen) with 10% FCS (Invitrogen) and 1% penicillin/strepto-
mycin (Invitrogen) for 7 DIV until a confluent glial cell layer (astro-
cytes and microglia) was formed. To induce microglial proliferation,
the mixed glial culture was stimulated from day 7 on with GM-CSF
(Miltenyi Biotec, 130-095-746) with a final concentration of 5 ng/ml.
Microglia were harvested at DIV 10–14 by 6 min of shaking. Microglial
identity was confirmed by immunostaining for Iba1 and CD68.
Adult animals were anesthetized with isoflurane, euthanized by
CO2, and transcardially perfused with 1× PBS. The brain was
removed and dissected, followed by homogenizing using the gentle
MACS Octo Dissociator (Miltenyi Biotec). Next, magnetic sorting
using CD11b+ magnetic beads (Miltenyi Biotec, 130-093-634) was
performed. Prior to (i.e., directly after tissue dissociation) and after
MACS sorting, isolated cells are stained with CD45 and CD11b anti-
bodies and analyzed by flow cytometry using the expression levels
of CD11b and of CD45 to distinguish resident microglia
(CD11b+CD45int) from other CNS macrophages (CD11b+CD45hi)
including meningeal macrophages or from other (systemic)
inflammatory cells such as peripheral leukocytes (CD11b-CD45hi).
Only isolations with a purity of 95% of CD11b-positive macro-
phages/microglia were used for further analysis.
After sorting, the cells were seeded on PLL-coated coverslips,
1 × 106 cells/well, and fixed with ice-cold methanol after 3 h at
37°C. Subsequently, they were stained for LC3 and NLRP3, see
Immunocytochemistry section.
Microglia treatment
Microglia from newborn mice were seeded in 24-well plates and
incubated overnight in growth medium DMEM (Invitrogen) with
10% FCS (Invitrogen) and 1% penicillin/streptomycin (Invitrogen)
without GM-CSF. Next day, cells were kept for 2 h in growth
medium or HBSS as indicated. As a pro-inflammatory stimulus, LPS
(final concentration 1 lg/ml) for 3 h followed by ATP (final concen-
tration 1 mM) for 45 min was used before supernatant and cells
were harvested. 3-MA (Sigma-Aldrich, M9282, final concentration
10 mM) was added 1 h 45 min before the end of the experiment. To
measure autophagic flux, microglia were kept for 2 h in cultivation
medium or HBSS (24020-091, Invitrogen) in the presence of Bafilo-
mycin A1 (Sigma-Aldrich, B1793, final concentration 5 nM).
siRNA transfection
Microglia were seeded as described above. Next day, medium was
exchanged and cells were transfected with a complex of Viromer Blue
(Lipocalyx, VB-01LB-00) and CALCOCO2 FlexiTube siRNA #4
(Qiagen, 1027416/GS76815), according to manufacturer’s instruction.
Every 2 days, fresh medium was added to the wells. Six days after
transfection, cells were stimulated with LPS/ATP as described above.
ELISA
The supernatant of stimulated microglia was diluted 1:10-1:20 or
used undiluted (IL-18). IL-1beta (eBioscience, 88701388), IL-18
(MBL, MBL-7625), TNFalpha (eBioscience, 88723477), and IL-6
(eBioscience, 88706488) concentration was determined according to
the manufacturer’s instructions.
The cytokine content as well as the amyloid-beta burden of the
whole brain was determined using a MESO QuickPlex SQ 120
system (Meso Scale Discovery) and the V-PLEX Pro-inflammatory
Panel 1 (Meso Scale Discovery, K15048D1) and the V-PLEX Ab
Peptide Panel 1 (4G8) (Meso Scale Discovery, K15199E), respec-
tively. Proteins were extracted from mouse brains using the four-
step protocol as described before (Kawarabayashi et al, 2001). The
TBS fraction and the Triton-X fraction containing the soluble
proteins were measured without further dilution. The SDS fraction
was diluted 1:500 prior to measuring insoluble proteins.
Western blotting
Protein lysates were separated by SDS–PAGE using (depending on
size) a Tris–Glycin or a Tris–Tricine buffer system and transferred by
wet blotting onto a nitrocellulose membrane. The following antibod-
ies were used: BECN1 (Novus, NB500-249 or Cell Signaling, 3495),
LC3 (Sigma, L8918), CASP1 and pro-CASP1 (Abcam, ab179515), IL-
1beta and pro-IL-1beta (eBioscience, 88701388), NLRP3 (AdipoGen,
AG-20B-0014), p62/SQSTM1 (MBL, PM045), CALCOCO2 (Abiocode,
R2269-1), and ACTIN (Sigma, A1978). For visualization of the
bands, the SuperSignal West Femto Chemiluminescent Substrate
(Thermo, 34096) for detection of horseradish peroxidase activity
was used. The quantification of the respective intensities of all bands
was achieved with the program ImageJ, and the amount of the
respective protein was normalized to the ACTIN protein content.
Phagocytosis assay in acute brain slices
The assay was performed as described before (Krabbe et al, 2013).
In brief, mice were decapitated and brains were carefully removed
and washed in carbogen-saturated artificial cerebrospinal fluid
(aCSF), pH 7.4. 130-lm-thick coronal slices were prepared using a
vibratome (Microm, Walldorf, Germany) at 4°C and were kept in
brain slice buffer at room temperature (21–25°C) for 2 h. The acute
brain slices were then incubated with a suspension of FCS-coated
yellow-green fluorescent carboxylated microspheres (2 lm diame-
ter, Polysciences Europe GmbH) at a concentration of 1.7 × 107
microspheres/ml for 60 min at 37°C, extensively washed, and
finally fixed with 4% paraformaldehyde. Brain sections were stained
with anti-Iba1 (Wako, 019-19741) antibody to visualize microglia.
Phagocytosis assay analysis
In brain sections derived from acute brain slices, z-stacks of 20 lm
thickness were produced using a 40× objective with a step size of
1 lm beginning at the top of the slice, where the microspheres are
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located. Beads per cell were counted using ImageJ cell counter
plugin ensuring that only beads inside a cell were counted as posi-
tive. The phagocytic index was determined by assessing the percent-
age of cells, which contained 0, 1–4, 5–7, 8–10, and > 10
microspheres per cell. The percentage of cells in each group was
multiplied by the corresponding grade of phagocytosis (1–4:1, 5–
7:2, 8–10:3, > 10:4). The sum of the products in each group was
then termed and displayed as phagocytic index (Krabbe et al, 2013).
Six ROIs (i.e., fields of view) were analyzed per animal.
Histology
Formalin-fixed and sucrose-treated brain hemispheres were frozen
and cryosectioned coronally at 30 lm. Tissue sections were
collected throughout the entire rostrocaudal extent of the brain and
stored at 4°C until staining. Immunohistochemistry and subsequent
stereological analyses were performed on 10–12 systematically
randomly sampled sections collected at 180-lm intervals for each
marker analyzed. Free-floating sections were stained for microglia
with the antibody Iba1 (1:500, Wako, 019-19741) or for amyloid-
beta using the antibody 4G8 (1:500, Covance, Sig39220-500). Core
plaques were stained with Congo red (Carl Roth).
Stereology
Stereology was performed using a Stereo Investigator system
(MicroBrightField) and DV-47d camera (MicroBrightField) mounted
on a BX53 microscope (Olympus). Stereological quantification of
Iba1+ cells and Congo red+ plaques was performed using the optical
fractionator method (MicroBrightField). Quantification of
4G8+ plaques was performed using the area fraction fractionator
method (MicroBrightField).
Immunocytochemistry
Co-staining of NLRP3 with LC3, p62, mitochondria, or CALCOCO2
Microglia were cultured overnight on Poly-L-Lysine-coated coverslips.
For visualization of mitochondria, cells were incubated for 1 h with
MitoTracker Red CMX ROS (MTR; Thermo Fisher # M7512) (final
concentration 25 nM) prior to stimulation. Autophagosomes were
stained according to Ktistakis (Ktistakis, 2015). Shortly, cells
were fixed with ice-cold methanol for 10 min and blocked overnight in
1× PBS with 2% bovine serum albumin. LC3 antibody (Sigma, L7543),
p62 (Santa Cruz, sc-25575), respectively, and CALCOCO2 antibody
(Proteintech, 12229-1-AP) were added for 1 h (1:200), followed by an
Alexa568-conjugated secondary antibody (Invitrogen, 11011) for 1 h
(1:500). Afterward, the NLRP3 antibody (AdipoGen, AG-20B-0014)
was added overnight (1:500), followed by an Alexa488-conjugated
secondary antibody (Invitrogen, 11001) for 1 h (1:500).
ASC
Microglia were cultured overnight on Poly-L-Lysine-coated cover-
slips, fixed with 4% paraformaldehyde for 20 min, permeabilized
with 0.1% Triton X-100 for 20 min, blocked with 3% bovine serum
albumin for 1–3 h in 1× PBS, and incubated overnight in PBS with
the primary antibody ASC (AdipoGen, AG-25B-0006, 1:500). Next
day, incubation with an Alexa568-conjugated secondary antibody
(Invitrogen, 11011) was performed for 1 h.
Nuclei were counterstained with DAPI (Roche, 10236276001).
Samples were mounted with Fluorescent Mounting Medium (Dako,
S3023).
Microscopy
Confocal laser scanning microscopy
A Leica TCS SP5 confocal laser scanning microscope controlled by
LAS AF scan software (Leica Microsystems, Wetzlar, Germany) was
used. Images were taken simultaneously and assembled to stacks.
LC3-positive vesicles, NLRP3 aggregates, and ASC specks were
counted with the program ImageJ and normalized on the cell area
(without the nuclear area), respectively, the cell number. Images in
the figures represent maximum image projections.
SIM
3D 3-color SIM images were acquired using the 405, 488, and
568 nm laser lines, standard filter sets, and 125 nm z-sectioning of
the OMX V4 Blaze (GE Healthcare) system. 100-nm fluorescent beads
(TetraSpeck, T7284, Thermo Fisher Scientific) were used for registra-
tion of the detection channels, achieving < 40 nm registration error
for all three channels. 3D-rendering, image and movie export was
done with Arivis Vision4D and ImageJ (Schneider et al, 2012).
Image analysis of SIM pictures
The centers (center of mass) of NLRP3 clusters or dapi-stained
nuclei were determined in SIM images with Arivis Vision4D using a
histogram-based threshold procedure (Otsu’s method). NLRP3 clus-
ters were additionally filtered with a size exclusion filter against
small objects (minimal diameter 500 nm). 3D radial intensity pro-
files around cluster centers were generated with a custom-written
ImageJ macro (Schneider et al, 2012). Averaged intensity values
were plotted against their radial distance to the center of mass of
single clusters in the reference channel (NLRP3). Distances between
NLRP3 clusters and the nucleus were calculated based on the
segmentation objects using a custom-written Python script.
Data analysis
Values are presented as mean  SEM (standard error of the mean).
Statistical difference between means was assessed either by the two-
tailed t-test for two groups or ANOVA with the indicated post hoc
test for more than two groups using the GraphPad Prism software.
Statistically significant values are indicated by *P < 0.05,
**P < 0.01, and ***P < 0.001.
Expanded View for this article is available online.
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